Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

NCT02175186 is registered in ClinicalTrials.gov with Young-Hak Kim, MD, PhD as lead sponsor.

NCT NCT02175186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02175186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Lead sponsor
Young-Hak Kim, MD, PhD
Phase
Phase 4
Overall status
Completed
Start date
January 21, 2015
Completion date
January 8, 2019
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastritis, gastroduodenal ulcer